Description

BSE announces listing and admission for trading of new securities issued under ESOP/ESOS schemes by 17 companies, effective December 31, 2025.

Summary

BSE has approved the listing and admission for trading of further securities issued by 17 companies under their Employee Stock Option Plans (ESOP) and Employee Stock Option Schemes (ESOS). These securities will be available for trading from December 31, 2025. The listing covers a total of 1,550,436 shares across companies in various sectors including banking, technology, pharmaceuticals, real estate, and industrial manufacturing. None of the shares are under lock-in.

Key Points

  • 17 companies issuing new securities under ESOP/ESOS schemes
  • Total securities listed: 1,550,436 shares across all companies
  • Largest issuance: IDFC First Bank Limited (796,222 shares, face value ₹10)
  • Second largest: Sai Life Sciences Limited (889,133 shares, face value ₹1)
  • All securities have no lock-in period restrictions
  • Securities available for trading from December 31, 2025
  • Companies span banking, IT, pharma, real estate, industrial, and chemical sectors

Regulatory Changes

No regulatory changes announced. This is a standard administrative notification for listing of employee stock options.

Compliance Requirements

No specific compliance requirements for market participants. This is an informational circular regarding securities that have been approved for listing and trading.

Important Dates

  • Notice Date: December 30, 2025
  • Trading Commencement Date: December 31, 2025 (Wednesday)

Impact Assessment

Market Impact: Minimal. The listing of ESOP/ESOS shares is a routine corporate action that represents employee compensation being converted to tradeable securities. The volumes involved are relatively small compared to the outstanding shares of these companies.

Company-Specific Impact:

  • Represents increased float for listed companies
  • Potential dilution effect is marginal given the small number of shares relative to existing equity base
  • No lock-in restrictions means shares are immediately tradeable

Investor Impact: Neutral. Existing shareholders may see minor dilution, but the impact is negligible given the small size of issuances relative to market capitalization of these companies.

Detailed Company List

CompanyISINScrip CodeSharesFace Value (₹)
Max India LimitedINE0CG60101654322320,00010
Aditya Birla Capital LtdINE674K01013540691120,05410
ArisInfra Solutions LimitedINE0H9P0102854441966,8702
BlackBuck LimitedINE0UIZ01018544288110,7151
Carborundum Universal LtdINE120A010345133756,8761
CG Power and Industrial Solutions LimitedINE067A010295000935,0002
DCB Bank LimitedINE503A0101553277232,62010
Emcure Pharmaceuticals LimitedINE168P010155442107,70010
Federal Bank LtdINE171A01029500469108,4612
IDFC First Bank LimitedINE092T01019539437796,22210
Infosys LtdINE009A0102150020943,4905
KFin Technologies LimitedINE138Y0101054372055,87910
Lodha Developers LimitedINE670K0102954328742,63010
Sai Life Sciences LimitedINE570L01029544306889,1331
Sudarshan Chemical Industries LtdINE659A010235066555,4632
The Phoenix Mills LtdINE211B010395031006,0002
Waaree Renewable Technologies LimitedINE299N0102153461899,2232

Impact Justification

Routine administrative listing of employee stock option shares for 17 companies. No impact on trading operations or investor obligations. Total shares being listed represent small fractions of respective companies' equity base.